Security National Bank of So Dak’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Security National Bank of So Dak’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,975	Closed	-$201K	–	98
2023 Q2	$201K	Buy	+1,975	New	+$187K	0.14%	97

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Security National Bank of So Dak's RETA Position: Q3 2023 in Review

Security National Bank of So Dak sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 1,975 shares — an estimated $201K sold.

Security National Bank of So Dak first reported a position in RETA in Q2 2023 and held it in 1 quarter. The position peaked at $201K in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Security National Bank of So Dak reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Security National Bank of So Dak sold 1,975 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $201K.
Security National Bank of So Dak first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Security National Bank of So Dak's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $201K in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Security National Bank of So Dak's 13F filing for Q3 2023, filed 13 Nov 2023.